Oct 9
Registration statement
F-4
Registration statement
Scancell’s July 23, 2026 merger agreement with Neuphoria provides approximately 3.77246 Scancell ADSs and one contingent value right per Neuphoria share; closing requires at least $75,000,000 in concurrent financing proceeds.